The ActiveCare+S.F.T.® system was designed with the objective of changing the landscape of DVT prevention from the use of anticoagulant drugs to the ActiveCare+S.F.T.® innovative mechanical system. The system's lightweight mobility, its capability to produce an optimal hemodynamic profile and its clinical efficacy and safety, offers patients and surgeons optimal DVT prevention without the risk of bleeding complications associated with the use of anticoagulants.
The ActiveCare+S.F.T.® system consists of a lightweight miniature mobile unit (1.65 lb), with compression sleeves that can be easily wrapped around the patient's lower limbs. The system can be operated either by rechargeable battery or the mains.
The ActiveCare+S.F.T.® system is a safe and highly effective way to reduce the risk of blood clot formation and prevent deep vein thrombosis (DVT), without the use of medications or increased risk of bleeding.
Due to its compact size, and ability to be worn 24/7 both in the acute care settings and post discharge, ActiveCare+S.F.T.® can achieve an exceptionally high compliance level, easily monitored on the unit's LCD screen.
ActiveCare+S.F.T.® is both FDA (510k) and CE (M.D.D.) approved and holds a TUV stamp and ISO 13485: 2003.
To view ActiveCare+S.F.T.® specifications, refer to our Product Specs 